Trevi Therapeutics, Inc.
TRVI • NASDAQ • Stock Fundamentals
Trevi Therapeutics, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Jennifer L. Good, with a market cap of $1.9B.
Market Cap$1.9B
Employees25.0
CEOJennifer L. Good
CountryUnited States of America
Healthcare
Biotechnology
Most Recent EarningsMay 5, 2026 · 1 month 9 days agoQ1 2026
View reportNext EarningsAug 6, 2026 · in 2 monthsAfter Market Close · Q2 2026
Financials
Based on Q1 2026 filing
TRV
Trevi Therapeutics, Inc. FAQ
Common questions about Trevi Therapeutics, Inc.
Trevi Therapeutics, Inc. (TRVI) has a market capitalization of $1.9B and trades on NASDAQ.
Trevi Therapeutics, Inc. has approximately 25 employees.